Colon Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colon Cancer, including details on causes, treatment, symptoms.

Volume 3 (2006), Issue 1 (January)

1. Antitumor benzothiazoles. 26.(1) 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines.
   J Med Chem, 49(1): 179-85. [Abstract] [Full-text]
2. Erybraedin C and bitucarpin A, two structurally related pterocarpans purified from Bituminaria bituminosa, induced apoptosis in human colon adenocarcinoma cell lines MMR- and p53-proficient and -deficient in a dose-, time-, and structure-dependent fashion.
   Chem Biol Interact, 159(2): 104-16. [Abstract] [Full-text]
3. Altered gene expression in normal colonic mucosa of individuals with polyps of the colon.
   Dis Colon Rectum, 48(12): 2329-35. [Abstract] [Full-text]
4. Pinealoblastoma in a patient with familial adenomatous polyposis: variant of Turcot syndrome type 2? Report of a case and review of the literature.
   Dis Colon Rectum, 48(12): 2343-6. [Abstract] [Full-text]
5. The significance of tumor markers for proliferation and apoptosis in predicting survival in colorectal cancer.
   Dis Colon Rectum, 48(12): 2197-208. [Abstract] [Full-text]
6. Immunogenic hsp-70 is overexpressed in colorectal cancers with high-degree microsatellite instability.
   Dis Colon Rectum, 48(12): 2322-8. [Abstract] [Full-text]
7. Gene expression profiling of nonneoplastic mucosa may predict clinical outcome of colon cancer patients.
   Dis Colon Rectum, 48(12): 2238-48. [Abstract] [Full-text]
8. Long-term outcome after ampullectomy for ampullary lesions associated with familial adenomatous polyposis.
   Dis Colon Rectum, 48(12): 2192-6. [Abstract] [Full-text]
9. Limited survival in the treatment of carcinomatosis from rectal cancer.
   Dis Colon Rectum, 48(12): 2258-63. [Abstract] [Full-text]
10. Optimal ligation level of the primary feeding artery and bowel resection margin in colon cancer surgery: the influence of the site of the primary feeding artery.
    Dis Colon Rectum, 48(12): 2232-7. [Abstract] [Full-text]
11. Reg IV activates the epidermal growth factor receptor/Akt/AP-1 signaling pathway in colon adenocarcinomas.
    Gastroenterology, 130(1): 137-49. [Abstract] [Full-text]
12. Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers.
    Br J Cancer, 94(1): 128-35. [Abstract] [Full-text]
13. Characterizations of irofulven cytotoxicity in combination with cisplatin and oxaliplatin in human colon, breast, and ovarian cancer cells.
    Cancer Chemother Pharmacol, 57(4): 491-9. [Abstract] [Full-text]
14. Pharmacokinetics and phototoxicity of purpurin-18 in human colon carcinoma cells using liposomes as delivery vehicles.
    Cancer Chemother Pharmacol, 57(4): 500-6. [Abstract] [Full-text]
15. Influence of obesity on the risk of developing colon cancer.
    Gut, 55(2): 285-91. [Abstract] [Full-text]
16. Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas.
    Gut, 55(2): 234-42. [Abstract] [Full-text]
17. Equivalent effect of DNA damage-induced apoptotic cell death or long-term cell cycle arrest on colon carcinoma cell proliferation and tumour growth.
    Oncogene, 25(2): 165-75. [Abstract] [Full-text]
18. Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1.
    Oncogene, 25(2): 278-87. [Abstract] [Full-text]
19. Mutant p53 gain of function: reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expression.
    Oncogene, 25(2): 304-9. [Abstract] [Full-text]
20. Colon cancer metastatic to the lung and the thyroid gland.
    Arch Surg, 141(1): 93-6. [Abstract] [Full-text]
21. The secreted form of the p40 subunit of interleukin (IL)-12 inhibits IL-23 functions and abrogates IL-23-mediated antitumour effects.
    Immunology, 117(1): 22-8. [Abstract] [Full-text]
22. Expression of a fibroblast growth factor-binding protein during the development of adenocarcinoma of the pancreas and colon.
    Cancer Res, 66(2): 1191-8. [Abstract] [Full-text]
23. The penetration of anticancer drugs through tumor tissue as a function of cellular adhesion and packing density of tumor cells.
    Cancer Res, 66(2): 1033-9. [Abstract] [Full-text]
24. Helicobacter infection is required for inflammation and colon cancer in SMAD3-deficient mice.
    Cancer Res, 66(2): 828-38. [Abstract] [Full-text]
25. Altered expression and localization of creatine kinase B, heterogeneous nuclear ribonucleoprotein F, and high mobility group box 1 protein in the nuclear matrix associated with colon cancer.
    Cancer Res, 66(2): 763-9. [Abstract] [Full-text]
26. De novo CpG island methylation in human cancer cells.
    Cancer Res, 66(2): 682-92. [Abstract] [Full-text]
27. Magnesium intake and reduced risk of colon cancer in a prospective study of women.
    Am J Epidemiol, 163(3): 232-5. [Abstract] [Full-text]
28. NO-donating aspirin isomers downregulate peroxisome proliferator-activated receptor (PPAR)delta expression in APC(min/+) mice proportionally to their tumor inhibitory effect: Implications for the role of PPARdelta in carcinogenesis.
    Carcinogenesis, 27(2): 232-9. [Abstract] [Full-text]
29. Effects of indole-3-carbinol and phenethyl isothiocyanate on colon carcinogenesis induced by azoxymethane in rats.
    Carcinogenesis, 27(2): 287-92. [Abstract] [Full-text]
30. Inhibition of Akt signaling and enhanced ERK1/2 activity are involved in induction of macroautophagy by triterpenoid B-group soyasaponins in colon cancer cells.
    Carcinogenesis, 27(2): 298-306. [Abstract] [Full-text]
31. The role of NO synthases in arginine-dependent small intestinal and colonic carcinogenesis.
    Mol Carcinog, 45(2): 93-105. [Abstract] [Full-text]
32. Induction of spermidine/spermine N1-acetyltransferase (SSAT) by aspirin in Caco-2 colon cancer cells.
    Biochem J, 394: 317-24. [Abstract] [Full-text]
33. Cyclooxygenase-2 expression and oxidative DNA adducts in murine intestinal adenomas: modification by dietary curcumin and implications for clinical trials.
    Eur J Cancer, 42(3): 415-21. [Abstract] [Full-text]
34. Exploring SNP-SNP interactions and colon cancer risk using polymorphism interaction analysis.
    Int J Cancer, 118(7): 1790-7. [Abstract] [Full-text]

© 2004-2008 Colon Cancer Research Today. All Rights Reserved.